WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011139525) STEREOISOMER OF NALOXONE AND POTENTIAL THERAPEUTIC ACTION OF OPIOID DRUGS TO REVERSE CLINICAL TOLERANCE TO THESE AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/139525    International Application No.:    PCT/US2011/032678
Publication Date: 10.11.2011 International Filing Date: 15.04.2011
IPC:
A61K 31/52 (2006.01), A61K 9/00 (2006.01), A61K 31/135 (2006.01)
Applicants: PHILADELPHIA HEALTH & EDUCATION CORPORATION [US/US]; D/b/a Drexel University College Of Medicine 245 N. 15th Street, Philadelphia, PA 19102 (US) (For All Designated States Except US).
SIMANSKY, Kenny, J. [US/US]; (US) (For US Only).
ALOYO, Vincent, J. [US/US]; (US) (For US Only).
CHAIJALE, Nayla, N. [AR/US]; (US) (For US Only)
Inventors: SIMANSKY, Kenny, J.; (US).
ALOYO, Vincent, J.; (US).
CHAIJALE, Nayla, N.; (US)
Agent: NGUYEN, Quang, D.; Riverside Law, LLP 300 Four Falls Corporate Center, Suite 710 300 Conshohocken State Road West Conshohocken, PA 19428 (US)
Priority Data:
61/331,659 05.05.2010 US
Title (EN) STEREOISOMER OF NALOXONE AND POTENTIAL THERAPEUTIC ACTION OF OPIOID DRUGS TO REVERSE CLINICAL TOLERANCE TO THESE AGENTS
(FR) STÉRÉOISOMÈRE DE NALOXONE ET ACTION THÉRAPEUTIQUE POTENTIELLE DE MÉDICAMENTS OPIOÏDES POUR INVERSER LA TOLÉRANCE CLINIQUE À CES AGENTS
Abstract: front page image
(EN)The present invention relates generally to methods of using (+) naloxone for managing feeding disorders and acute debilitating disorders such as pain, Also encompassed by the invention is the use of (+) naloxone to manage any disease, disorder or condition associated with mu opioid receptors (MOPR).
(FR)La présente invention concerne généralement des procédés d'utilisation de la (+)-naloxone pour contrôler des troubles alimentaires et des troubles débilitants aigus tels que la douleur. La présente invention concerne en outre l'utilisation de la (+)-naloxone pour contrôler une maladie, un trouble ou une affection associés à des récepteurs d'opioïde mu (MOPR).
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)